Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CES1 | P23141 | 6/20 | 0.39 |
| ▸ | CES2 | O00748 | 6/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10599714 | 0.98 | CA1 (0.41) | CA1CES1CES2CYP4F2CYP4A11 | |
| Silver SCHEMBL25380476 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL10495891 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL6889313 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL17472936 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| Zinc Ion SCHEMBL546648 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL8939650 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL17476400 | 0.95 | CA1 (0.44) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL652779 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 | |
| SCHEMBL6277014 | 0.95 | CA1 (0.39) | CA1CES1CES2CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4636846-A1 | SODIUM COMPENSATION MATERIAL, PREPARATION METHOD THEREOF, POSITIVE ELECTRODE PLATE, AND SODIUM-ION BATTERY | Xiamen Hithium Energy Storage Technology Co., Ltd. (CN) | 2025-10-22 | — | — | EP | claimed |
| US-20250293259-A1 | SODIUM COMPENSATION MATERIAL, PREPARATION METHOD THEREOF, POSITIVE ELECTRODE PLATE, AND SODIUM-ION BATTERY | Xiamen Hithium Energy Storage Technology Co., Ltd. (CN) | 2025-09-18 | — | — | US | claimed |
| CN-118867247-A | Sodium supplementing material, preparation method thereof, positive electrode plate and sodium ion battery | 厦门海辰储能科技股份有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118198364-A | Sodium supplementing material, preparation method thereof, positive electrode plate and sodium ion battery | 厦门海辰储能科技股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| EP-1077073-B1 | Resorbable copolylactides and their use | JUERGENS CHRISTIAN DR MED (DE) | 2004-10-13 | — | — | EP | claimed |
| EP-0782865-B1 | Use of lactide polymers for prevention of adhesion | JUERGENS CHRISTIAN DR MED (DE) | 2001-08-29 | — | — | EP | claimed |
| US-20260109890-A1 | METHOD FOR REDUCING COEFFICIENT OF FRICTION OF A LAMINATE COMPRISING A POLYURETHANE ADHESIVE | ARKEMA FRANCE (FR) | 2026-04-23 | — | — | US | disclosed |
| US-12600890-B2 | Solventless adhesive compositions and laminate materials prepared therefrom | ARKEMA FRANCE (FR) | 2026-04-14 | — | — | US | disclosed |
| EP-4709775-A1 | FOAM FORMULATIONS | Dow Global Technologies LLC (US) | 2026-03-18 | — | — | EP | disclosed |
| EP-4004078-B1 | FORMULATED POLYOL COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-02-25 | — | — | EP | disclosed |
| EP-4402196-B1 | ZEOLITE CONTAINING POLYOLEFIN FILMS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-12528980-B2 | Method for reducing coefficient of friction of a laminate comprising a polyurethane adhesive | ARKEMA FRANCE (FR) | 2026-01-20 | — | — | US | disclosed |
| EP-4673489-A1 | LOW VISCOSITY POLYURETHANE ACRYLATE HYBRID COMPOSITION FOR RIGID AND TOUGH PRODUCTS | Dow Global Technologies LLC (US) | 2026-01-07 | — | — | EP | disclosed |
| US-5492941-A | FOAMS CONTAINING CROSSLINKED POLY(METH)ACRYLIC ACIDS, THEIR SALTS AND/OR POLY(METH)ACRYLAMIDES AS ADDITIVES | BASF SCHWARZHEIDE GMBH (DE) | 1996-02-20 | — | — | US | disclosed |
| US-5488070-A | POLYMERIZATION IN THE PRESENCE OF A POLY(METH)ACRYLIC ACID OR POLY(METH)ACRYLAMIDE, IMPROVED WATER ABSORPTION | BASF SCHWARZHEIDE GMBH (DE) | 1996-01-30 | — | — | US | disclosed |
| US-5334620-A | Production of chlorofluorocarbon-free, urethane-containing moldings having a cellular core and a compacted peripheral zone | BASF AKTIENGESELLSCHAFT (DE) | 1994-08-02 | — | — | US | disclosed |
| US-5306798-A | Transparent, autoclavable, non-cytotoxic, essentially compact polyurethane embedding compositions, the preparation thereof and the use thereof, especially for articles used in medicine | BASF AKTIENGESELLSCHAFT (DE) | 1994-04-26 | — | — | US | disclosed |
| US-5254597-A | Production of chlorofluorocarbon-free, urethane-containing moldings having a cellular core and a compacted peripheral zone | BASF A.G. (DE) | 1993-10-19 | — | — | US | disclosed |
| US-5173518-A | Containing polyoxytetramethylene glycol radicals and chain extender or crosslinking agent | BASF AKTIENGESELLSCHAFT (DE) | 1992-12-22 | — | — | US | disclosed |
| US-5110834-A | PRODUCTION OF CHLOROFLUOROCARBON-FREE URETHANE-CONTAINING SOFT-ELASTIC MOLDINGS HAVING A CELLULAR CORE AND A COMPACTED PERIPHERAL ZONE | BASF AKTIENGESELLSCHAFT (DE) | 1992-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528980-B2 | Method for reducing coefficient of friction of a laminate comprising a polyurethane adhesive | MACF1, ICAM1, VIM | CA1 2056/4885CES1 3519/4885CES2 2094/4885 |
| US-12600890-B2 | Solventless adhesive compositions and laminate materials prepared therefrom | MACF1, ICAM1, CDH1 | CA1 4592/4885CES1 4006/4885CES2 3988/4885 |
| US-20260109890-A1 | METHOD FOR REDUCING COEFFICIENT OF FRICTION OF A LAMINATE COMPRISING A POLYURETHANE ADHESIVE | MACF1, ICAM1, VCL | CA1 2719/4885CES1 3994/4885CES2 2193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.